In the UK, annual influenza immunisation is advised for everyone aged 65 years and over. Immunisation can reduce the incidence of infection and has been shown to reduce morbidity and mortality in both institutionalised and non-institutionalised older people. Dr Steve Allsup explores the pharmacoeconomic evidence base to determine whether vaccinating all people over 65 years represents a cost effective strategy.